Product Information
TEMOZOLOMIDE 180 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $21.4132 per EA under NDC 31722041514. Its NADAC has been published 45 times since May 7, 2025.
FDA first approved this application on Aug 23, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722041514
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/7/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210030FDA Approved
8/23/2024
TE Code
AB
On Market Since
8/23/2024
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 180 MG CAPSULE has been published 45 times since May 7, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.4132 per EA |
|---|---|
| All-time high | $21.4132 (Mar 11, 2026) |
| All-time low | $21.4132 (May 7, 2025) |
| 52-week high | $21.4132 |
| 52-week low | $21.4132 |
| Median price | $21.4132 |
| Average price | $21.4132 |
| Largest weekly change | 0.0% (May 14, 2025) |
| Weeks tracked | 45 |
| Tracking since | May 7, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 180 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $21.4132 per EA (NDC 31722041514), effective Mar 11, 2026.
How has the price of TEMOZOLOMIDE 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 45 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 180 MG CAPSULE?
Since May 7, 2025, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has ranged from a low of $21.4132 (May 7, 2025) to a high of $21.4132 (Mar 11, 2026), with a median of $21.4132 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 180 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TEMOZOLOMIDE 180 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 180 MG CAPSULE?
TEMOZOLOMIDE 180 MG CAPSULE (NDC 31722041514) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.